(Reuters) - AstraZeneca topped analysts' estimates for quarterly profit and reiterated its targets for the year on Wednesday, as the British drugmaker benefited from higher demand for some of its ...
(Reuters) - British drugmaker AstraZeneca forecast revenue growth for this year of around 10% on Friday, as it factored in a hit from the coronavirus outbreak in China and fell short of analysts' ...
AstraZeneca has scrapped an asthma program after the FLAP inhibitor flopped in a phase 2 trial. | AstraZeneca has scrapped an ...
"These early results hold promise," Sarah Gilbert, the University of Oxford professor leading the research on the vaccine ...
The World Health Organisation (WHO) identifies Non-Communicable Diseases (NCDs) as the number one cause of death worldwide [1], disproportionately affecting people in low and middle income countries ...
--Best four day stretch since the four days ending July 17, 2020, when it rose 14.76% --Up 25.24% year-to-date; on pace for best year since 2019, when it rose 31.28% --Down 6.35% from its all-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results